Answers are grounded in this paper and cite their sources.
Introduction : Vitamin B12 (B12) is absorbed at the terminal ileum. Patients with Crohn's disease (CD) and ileal involvement or resection of the terminal ileum (RTI) are at risk of B12 deficiency. No standard recommendations on the monitoring and supplementation of B12 after non-extensive RTI are available. Our aims were to describe B12 supplementation modalities in clinical practice in patients with CD and RTI. Methods Retrospective, single-centre study that included patients with CD who underwent RTI between January 2008 and October 2022. B12 levels, supplementation, indication and route of administration after RTI and during follow-up were recorded. Results One-hundred and ninety-seven patients were included. Thirteen (7%) patients were on B12 supplementation prior to RTI. Seventy-nine patients (40%) were not supplemented and did not develop B12 deficiency. B12 supplementation was prescribed for 60% of patients during follow-up (6% of whom were already supplemented before surgery), 53% preventively after surgery and 47% after B12 deficiency. Intramuscular administration was the most common (97%, mainly monthly) and oral administration was limited (11%, mainly weekly). During follow-up, changes to the B12 supplementation schedule occurred in 36% (mainly prolonging the interval of intramuscular administration). RTI length ≥ 20cm (OR 1.944, 95% CI 1.019–3.709; P = 0.042) was the only factor associated with the development B12 deficiency during follow-up. Conclusions The B12 supplementation pattern in patients with CD and RTI is heterogeneous. Recommendations on supplementation and monitoring strategies are warranted to optimize its management in clinical practice.
No takes yet. Share an insight, caveat, or question.
Pèlach et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: